Aytu BioPharma, Inc. (AYTU) vs SCYNEXIS, Inc. (SCYX)
Aytu BioPharma, Inc. and SCYNEXIS, Inc. are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $45.0M against $25.1M — 1.8× the size. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against −13.3%. Aytu BioPharma, Inc. has the higher net margin (−24.8% vs −49.7%) and the higher return on invested capital (−20.0% vs −110.7%). Across the 18 metrics below, Aytu BioPharma, Inc. leads on 9 and SCYNEXIS, Inc. on 9.
Valuation
Profitability
| Metric | AYTU | SCYX | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 63.95% | 100.00% | 53.94% |
| Operating margin | (14.44%) | (109.90%) | 0.00% |
| Net margin | (24.76%) | (49.74%) | 0.00% |
| Free cash flow margin | 5.62% | (64.67%) | 0.00% |
| Return on equity | (52.55%) | (18.38%) | (0.40%) |
| Return on assets | (12.44%) | (15.09%) | (3.32%) |
| Return on invested capital | (19.99%) | (110.72%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack